US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

AEZS

Aeterna Zentaris (AEZS)

Aeterna Zentaris Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:AEZS

1 2 3 4 5 6 7 8 9 10 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
28/03/2024	06:55	GlobeNewswire Inc.	Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris	NASDAQ:AEZS	Aeterna Zentaris Inc
27/03/2024	07:05	GlobeNewswire Inc.	Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	NASDAQ:AEZS	Aeterna Zentaris Inc
12/03/2024	13:10	GlobeNewswire Inc.	Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	NASDAQ:AEZS	Aeterna Zentaris Inc
26/02/2024	06:30	GlobeNewswire Inc.	Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company	NASDAQ:AEZS	Aeterna Zentaris Inc
15/02/2024	16:50	GlobeNewswire Inc.	Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro	NASDAQ:AEZS	Aeterna Zentaris Inc
15/02/2024	15:54	Edgar (US Regulatory)	Form F-1 - Registration statement for certain foreign private issuers	NASDAQ:AEZS	Aeterna Zentaris Inc
15/02/2024	08:33	Edgar (US Regulatory)	Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]	NASDAQ:AEZS	Aeterna Zentaris Inc
22/12/2023	15:42	Edgar (US Regulatory)	Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]	NASDAQ:AEZS	Aeterna Zentaris Inc
14/12/2023	06:50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:AEZS	Aeterna Zentaris Inc
14/12/2023	06:50	GlobeNewswire Inc.	Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company	NASDAQ:AEZS	Aeterna Zentaris Inc
09/11/2023	07:00	GlobeNewswire Inc.	Aeterna Zentaris Reports Third Quarter 2023 Financial Results	NASDAQ:AEZS	Aeterna Zentaris Inc
11/10/2023	07:00	GlobeNewswire Inc.	Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference	NASDAQ:AEZS	Aeterna Zentaris Inc
05/09/2023	07:00	GlobeNewswire Inc.	Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:AEZS	Aeterna Zentaris Inc
09/08/2023	07:05	GlobeNewswire Inc.	Aeterna Zentaris Reports Second Quarter 2023 Financial Results	NASDAQ:AEZS	Aeterna Zentaris Inc
13/07/2023	06:30	GlobeNewswire Inc.	Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update	NASDAQ:AEZS	Aeterna Zentaris Inc
05/07/2023	07:45	GlobeNewswire Inc.	Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series	NASDAQ:AEZS	Aeterna Zentaris Inc
14/06/2023	15:43	Edgar (US Regulatory)	Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)	NASDAQ:AEZS	Aeterna Zentaris Inc
14/06/2023	15:05	GlobeNewswire Inc.	Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders	NASDAQ:AEZS	Aeterna Zentaris Inc
15/05/2023	15:05	GlobeNewswire Inc.	Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders	NASDAQ:AEZS	Aeterna Zentaris Inc
11/05/2023	05:07	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AEZS	Aeterna Zentaris Inc
09/05/2023	16:00	GlobeNewswire Inc.	Aeterna Zentaris Reports First Quarter 2023 Financial Results	NASDAQ:AEZS	Aeterna Zentaris Inc
05/04/2023	06:55	GlobeNewswire Inc.	Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trial	NASDAQ:AEZS	Aeterna Zentaris Inc
23/03/2023	07:08	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:AEZS	Aeterna Zentaris Inc
23/03/2023	07:05	GlobeNewswire Inc.	Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results	NASDAQ:AEZS	Aeterna Zentaris Inc
16/03/2023	07:05	GlobeNewswire Inc.	Pharmanovia to Market GHRYVELIN™ (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)	NASDAQ:AEZS	Aeterna Zentaris Inc
17/01/2023	07:05	GlobeNewswire Inc.	Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones	NASDAQ:AEZS	Aeterna Zentaris Inc
10/01/2023	07:05	GlobeNewswire Inc.	Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Event	NASDAQ:AEZS	Aeterna Zentaris Inc
03/11/2022	07:05	GlobeNewswire Inc.	Aeterna Zentaris Reports Third Quarter 2022 Financial Results	NASDAQ:AEZS	Aeterna Zentaris Inc
06/09/2022	05:15	TipRanks	H.C. Wainwright Reaffirms Their Buy Rating on Aeterna Zentaris (AEZS)	NASDAQ:AEZS	Aeterna Zentaris Inc
29/08/2022	07:00	GlobeNewswire Inc.	Aeterna Zentaris Set to Regain Full Rights to Macrilen™ (Macimorelin) in U.S. and Canada from Novo Nordisk	NASDAQ:AEZS	Aeterna Zentaris Inc

Showing the most relevant articles for your search:NASDAQ:AEZS

1 2 3 4 5 6 7 8 9 10 Próxima >

Health Care Select Sector

Financial Select Sector

Verizon Communications

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones